Literature DB >> 14023821

The combined use of insulin, tolbutamide and biguanides in the treatment of diabetes mellitus. Clinical significance and experimental findings.

W CREUTZFELDT, H D SOELING, Z ZARDAY.   

Abstract

Entities:  

Keywords:  DIABETES MELLITUS; INSULIN; TOLBUTAMIDE

Mesh：

Substances：

Year:  1963        PMID： 14023821

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  5 in total

1.  Plasma glucagon suppression by phenformin in man.

Authors:  N V Bohannon; J H Karam; M Lorenzi; J E Gerich; S B Matin; P H Forsham
Journal:  Diabetologia       Date:  1977-09       Impact factor: 10.122

2.  Failure of the biguanides to improve the control of unstable diabetes treated with insulin.

Authors:  J Pirart
Journal:  Diabetologia       Date:  1971-08       Impact factor: 10.122

3.  [Non-indicated insulin treatment].

Authors:  B Knick; O Wendt; P Netter; M L Konder; B Friedel
Journal:  Acta Diabetol Lat       Date:  1970 May-Jun

4.  Inhibition of intestinal absorption and improvement of oral glucose tolerance by biguanides in the normal and in the streptozotocin-diabetic rat.

Authors:  E Lorch
Journal:  Diabetologia       Date:  1971-06       Impact factor: 10.122

5.  [Study on the effect of phenethylbiguanide on responses to insulin, tolbutamide and glucose in diabetes mellitus].

Authors:  A Czyzyk; J Lawecki
Journal:  Diabetologia       Date:  1966-06       Impact factor: 10.122
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.